A Study Of Galcanezumab In Participants With Episodic Cluster Headache
Public ClinicalTrials.gov record NCT02397473. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Cluster Headache
Study identification
- NCT ID
- NCT02397473
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 109 participants
Conditions and interventions
Conditions
Interventions
- Galcanezumab Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 21, 2015
- Primary completion
- Feb 11, 2018
- Completion
- Jun 3, 2018
- Last update posted
- Sep 8, 2019
2015 – 2018
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cedars Sinai Medical Center | Los Angeles | California | 90048 | — |
| Stanford University Hospital | Palo Alto | California | 94304 | — |
| California Medical Clinic for Headache | Santa Monica | California | 90404 | — |
| Colorado Neurological Institute | Englewood | Colorado | 80113 | — |
| New England Institute for Clinical Research | Stamford | Connecticut | 06905 | — |
| Mayo Clinic-Jacksonville | Jacksonville | Florida | 32224 | — |
| University of Miami | Miami | Florida | 33136 | — |
| St. Anthony's Hospital | St. Petersburg | Florida | 33705 | — |
| Tampa General Hospital | Tampa | Florida | 33606 | — |
| Atlanta Center of Medical Research | Atlanta | Georgia | 30331 | — |
| Michigan Head, Pain, and Neurological Institute | Ann Arbor | Michigan | 48104 | — |
| ClinVest | Springfield | Missouri | 65807 | — |
| Dent Neurological Institute | Amherst | New York | 14226 | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| Clinical Trials of South Carolina | Charleston | South Carolina | 29406 | — |
| Northwest Clinical Research Center | Bellevue | Washington | 98007-4209 | — |
| West Virginia University Hospital | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02397473, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 8, 2019 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02397473 live on ClinicalTrials.gov.